Functional validation of a role for the candidate gene Ctr9 in psychostimulant action

候选基因 Ctr9 在精神兴奋作用中的作用的功能验证

基本信息

项目摘要

The mechanisms that mediate substance abuse liability are incompletely understood and therapeutic interventions for psychostimulant addiction remain largely ineffective. We conducted a genome-wide association study in Drosophila and identified the gene Ctr9 to be significantly associated with the locomotor response to amphetamine. Ctr9 is known to play a role in regulating gene expression as part of the Paf1C transcription complex. It was also shown in one publication to interact with the dopamine transporter, the major molecular target of psychostimulants. We have validated the role of Ctr9 in amphetamine-induced hyperactivity in flies; dopamine neuron-specific knockdown of Ctr9 leads to a dramatic increase in the response to amphetamine and methamphetamine, whereas its overexpression blunts the response. We have also shown that Ctr9 co-localizes with dopamine transporter (DAT) outside of the nucleus in dopamine neurons in the adult fly brain. We now aim to characterize the mechanisms underlying its effects on dopamine neurotransmission and methamphetamine- induced behavior in Drosophila and to develop a genetic model to functionally validate the role of Ctr9 in methamphetamine- and cocaine-induced hyperlocomotion in rats, which are uniquely suited to model traits that mimic compulsive drug-seeking behavior in humans and will thus facilitate our long-term goal to investigate the role of Ctr9 in addiction-like behavior. In pursuit of these goals, we propose the following specific aims: (1) To elucidate the mechanisms by which Ctr9 modulates methamphetamine-induced locomotor activity in flies. (a) We will use 2-photon imaging of a dopamine biosensor to determine the impact of Ctr9 knockdown and overexpression on optogenetically-evoked and methamphetamine-induced dopamine release. (b) To determine if the nuclear localization of Ctr9 is essential for its role in dopamine-mediated locomotor activity in Drosophila, we will express a truncated Ctr9 protein that is blocked from translocating to the nucleus (Ctr9ΔSH2) and test its impact on basal and methamphetamine-induced locomotion. (c) We will knock down the expression of Ctr9 strictly during adulthood, and at different times during development, to determine if Ctr9 knockdown interferes with early neurodevelopment to influence susceptibility to methamphetamine later in life or if it acts acutely during adulthood to modulate methamphetamine-induced behavior. (2) To establish a role for Ctr9 in the behavioral response to methamphetamine in rats and determine its impact on dopamine neurotransmission and DAT function. We will (a) generate a conditional Ctr9 knockout rat using a CRISPR/Cas9-mediated “Germline Gene Targeting” approach and (b) test the effects of deleting Ctr9 selectively in dopamine neurons on basal and methamphetamine- and cocaine-induced hyperactivity. (c) We will test the impact of selective knockout of Ctr9 in dopamine neurons on DAT cell-surface localization, evoked dopamine release, uptake and methamphetamine-induced dopamine efflux in striatal brain slices.
调节药物滥用倾向的机制尚未完全了解, 对精神兴奋剂成瘾的干预措施基本上仍然无效。我们进行了一个全基因组关联 在果蝇中进行的研究,并确定了基因Ctr 9与运动反应显着相关, 安非他明已知Ctr 9作为Paf 1C转录的一部分在调节基因表达中起作用 复杂.在一篇文章中,它还显示出与多巴胺转运蛋白(多巴胺转运蛋白的主要分子)相互作用。 精神兴奋剂的目标我们已经验证了Ctr 9在安非他明诱导的果蝇多动症中的作用; 多巴胺神经元特异性敲除Ctr 9导致对安非他明的反应急剧增加, 甲基苯丙胺,而它的过度表达减弱了反应。我们还表明,Ctr 9共定位 与成年果蝇脑中多巴胺神经元的核外多巴胺转运蛋白(DAT)。我们现在的目标是 以表征其对多巴胺神经传递和甲基苯丙胺影响的机制- 诱导的行为,并开发一个遗传模型,以功能验证Ctr 9的作用, 甲基苯丙胺和可卡因诱导的大鼠过度运动,这是唯一适合模型的特点, 模仿人类的强迫性药物寻求行为,从而将有助于我们的长期目标, Ctr 9在成瘾行为中的作用为实现这些目标,我们提出以下具体目标: (1)阐明Ctr 9调节甲基苯丙胺诱导的运动活动的机制 苍蝇。(a)我们将使用多巴胺生物传感器的双光子成像来确定Ctr 9敲低的影响。 以及过表达对光遗传学诱发的和甲基苯丙胺诱导的多巴胺释放的影响。(b)到 确定Ctr 9的核定位是否对其在多巴胺介导的运动活性中的作用至关重要, 在果蝇中,我们将表达一种截短的Ctr 9蛋白,该蛋白被阻止易位到细胞核(Ctr 9 Δ SH 2)。 并测试其对基础运动和甲基苯丙胺诱导的运动的影响。(c)我们会推翻 严格在成年期以及发育期间的不同时间对Ctr 9进行敲除,以确定Ctr 9是否被敲除 干扰早期神经发育,影响后期对甲基苯丙胺的易感性, 在成年期急性调节甲基苯丙胺诱导的行为。 (2)为了确定Ctr 9在大鼠对甲基苯丙胺的行为反应中的作用,并确定其在大鼠中的作用。 影响多巴胺神经传递和DAT功能。我们将(a)生成条件性Ctr 9敲除 使用CRISPR/Cas9介导的“生殖系基因靶向”方法对大鼠进行检测,以及(B)测试缺失Ctr 9的效果 选择性地在多巴胺神经元基础和甲基苯丙胺和可卡因诱导的多动症。(c)我们 将测试选择性敲除多巴胺神经元中的Ctr 9对DAT细胞表面定位、纹状体脑切片中诱发的多巴胺释放、摄取和甲基苯丙胺诱导的多巴胺流出的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan A Javitch其他文献

Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base
  • DOI:
    10.1186/1471-2105-8-177
  • 发表时间:
    2007-05-30
  • 期刊:
  • 影响因子:
    3.300
  • 作者:
    Lucy Skrabanek;Marta Murcia;Michel Bouvier;Lakshmi Devi;Susan R George;Martin J Lohse;Graeme Milligan;Richard Neubig;Krzysztof Palczewski;Marc Parmentier;Jean-Philippe Pin;Gerrit Vriend;Jonathan A Javitch;Fabien Campagne;Marta Filizola
  • 通讯作者:
    Marta Filizola

Jonathan A Javitch的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan A Javitch', 18)}}的其他基金

Impact of metabotropic glutamate receptor heteromerization on signaling and pharmacology
代谢型谷氨酸受体异聚化对信号传导和药理学的影响
  • 批准号:
    10637938
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
Development of dopamine D2 receptor-targeted DARTs
多巴胺 D2 受体靶向 DART 的开发
  • 批准号:
    10376835
  • 财政年份:
    2021
  • 资助金额:
    $ 19.99万
  • 项目类别:
Probing mechanisms of amphetamine action at plasma membrane and vesicular transporters in vitro and in vivo
体外和体内苯丙胺对质膜和囊泡转运蛋白作用的探讨机制
  • 批准号:
    9449417
  • 财政年份:
    2017
  • 资助金额:
    $ 19.99万
  • 项目类别:
Probing mechanisms of amphetamine action at plasma membrane and vesicular transporters in vitro and in vivo
体外和体内苯丙胺对质膜和囊泡转运蛋白作用的探讨机制
  • 批准号:
    9311046
  • 财政年份:
    2017
  • 资助金额:
    $ 19.99万
  • 项目类别:
Modulation of dopaminergic neurotransmission by ADGRL3, an adhesion GPCR associated with ADHD susceptibility
ADGRL3(一种与 ADHD 易感性相关的粘附 GPCR)对多巴胺能神经传递的调节
  • 批准号:
    9350414
  • 财政年份:
    2016
  • 资助金额:
    $ 19.99万
  • 项目类别:
Modulation of dopaminergic neurotransmission by ADGRL3, an adhesion GPCR associated with ADHD susceptibility
ADGRL3(一种与 ADHD 易感性相关的粘附 GPCR)对多巴胺能神经传递的调节
  • 批准号:
    9227923
  • 财政年份:
    2016
  • 资助金额:
    $ 19.99万
  • 项目类别:
Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model
使用果蝇行为模型描述安非他明敏感性的遗传基础
  • 批准号:
    9920454
  • 财政年份:
    2016
  • 资助金额:
    $ 19.99万
  • 项目类别:
Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model
使用果蝇行为模型描述安非他明敏感性的遗传基础
  • 批准号:
    9920689
  • 财政年份:
    2016
  • 资助金额:
    $ 19.99万
  • 项目类别:
Delineating the genetic basis of amphetamine sensitivity using a Drosophila behavioral model
使用果蝇行为模型描述安非他明敏感性的遗传基础
  • 批准号:
    10160626
  • 财政年份:
    2016
  • 资助金额:
    $ 19.99万
  • 项目类别:
Single-molecule and ensemble imaging of GPCR-G protein complexes in live cells
活细胞中 GPCR-G 蛋白复合物的单分子和整体成像
  • 批准号:
    8880249
  • 财政年份:
    2014
  • 资助金额:
    $ 19.99万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了